← 產業報告目錄
AI-based Clinical Trial Solutions for Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others), By End-Use, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-02-20頁數 180報告編號 INSIGHTACE-d099c16859
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 469.2 Million as of 2024, the global AI-based Clinical Trial Solutions for Patient Matching Market is anticipated to climb to USD 6205.4 Million by 2034, reflecting a compound annual growth rate of 29.6% over the 2025–2034 period.
AI-based Clinical Trial Solutions for Patient Matching encompasses key industry insights & findings from the report:
The growing influence of artificial intelligence and machine learning on clinical trials maps out the future growth of this quickly developing fie. The sector has gained traction as organizations seek innovative approaches to address evolving technology and communications challenges.
The market's upward path is propelled by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in technology and communications.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Based Clinical Trial Solutions for Patient Matching Market Snapshot
Chapter 4. Global AI-Based Clinical Trial Solutions for Patient Matching Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Therapeutic Application Estimates & Trend Analysis
5.1. by Therapeutic Application & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapeutic Application:
5.2.1. Oncology
5.2.2. Cardiovascular Diseases
5.2.3. Neurological Diseases or Conditions
5.2.4. Metabolic Diseases
5.2.5. Infectious Diseases
5.2.6. Others
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-users:
6.2.1. Pharmaceutical Companies
6.2.2. Academia
6.2.3. Others
Chapter 7. AI-Based Clinical Trial Solutions for Patient Matching Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America AI-Based Clinical Trial Solutions for Patient Matching Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Application, 2021-2034
7.1.2. North America AI-Based Clinical Trial Solutions for Patient Matching Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.1.3. North America AI-Based Clinical Trial Solutions for Patient Matching Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by Therapeutic Application, 2021-2034
7.2.2. Europe AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by End-users, 2021-2034
7.2.3. Europe AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by Therapeutic Application, 2021-2034
7.3.2. Asia Pacific AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by End-users, 2021-2034
7.3.3. Asia Pacific AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by Therapeutic Application, 2021-2034
7.4.2. Latin America AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by End-users, 2021-2034
7.4.3. Latin America AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by Therapeutic Application, 2021-2034
7.5.2. Middle East & Africa AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by End-users, 2021-2034
7.5.3. Middle East & Africa AI-Based Clinical Trial Solutions for Patient Matching Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Unlearn.AI, Inc.
8.2.2. Antidote Technologies, Inc.
8.2.3. Deep6.ai
8.2.4. Mendel.ai
8.2.5. Aris Global
8.2.6. Deep Lens AI
8.2.7. AmerisourceBergen Corporation
8.2.8. Konaks
8.2.9. Microsoft Corporation
8.2.10. GNS Healthcare
8.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們